The human placenta is a source of hematopoietic stem and progenitor cells (HSPCs). The RUNX1 transcription factor is required for the formation of functional HSPCs. The impact of preeclampsia (PE) and preterm labor (PTL, spontaneous preterm labor [sPTL] and inflammatory preterm labor [iPTL]) on HSPC localization and RUNX1 expression in the human placenta is unknown.
Methods:
We compared the frequency and density of HSPC in control samples from sPTL (n = 6) versus PE (n = 6) and iPTL (n = 6). We examined RUNX1 protein and RNA expression in placentas from normal pregnancies (5-22 weeks, n = 8 total) and in placentas from the aforementioned pregnancy complications (n = 5/group).
Results:
Hematopoietic stem and progenitor cells were rare cell types, associated predominantly with the vasculature of placental villi. The HSPC density was greater in the chorionic plate (CP) compared to the villi (P < .001) and greater in PE and iPTL samples as compared to controls within the CP (not significant) and overall (P < .05). During the fetal period, RUNX1 was expressed in the mesenchyme of the CP and villi. Inflammatory PTL samples were more likely to exhibit intraluminal RUNX1+ cell populations (P < .001) and RUNX1+ cell clusters attached to arterial endothelial cells.
Conclusion:
Placental HSPCs likely arise from hematopoietic niches comprised RUNX1+ mesenchyme and vascular endothelium. Pregnancy complications that result in preterm birth differentially affect placental HSPC localization and RUNX1 expression. Our results support previous findings that inflammation positively regulates hematopoiesis. We present new evidence that hemogenic endothelium may be active at later stages of human fetal development in the context of inflammation.
BarcenaAMuenchMOKapidzicMFisherSJ. A new role for the human placenta as a hematopoietic site throughout gestation. Reprod Sci. 2009;16(2):178–187.
2.
RobinCBollerotKMendesS. Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell. 2009;5(4):385–395.
3.
SerikovVHounshellCLarkinS. Human term placenta as a source of hematopoietic cells. Exp Biol Med (Maywood). 2009;234(7):813–823.
4.
IvanovsARybtsovSWelchLAndersonRATurnerMLMedvinskyA. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J Exp Med. 2011;208(12):2417–2427.
5.
BarcenaAMuenchMOKapidzicMGormleyMGoldfienGAFisherSJ. Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion. 2011;51(suppl 4):94S–105S.
6.
RhodesKEGekasCWangY. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell. 2008;2(3):252–263.
7.
BárcenaAMuenchMOKapidzicMGormleyMFisherSJ. The human term placenta as a source of transplantable hematopoietic stem cells. In: AtalaAMurphySV, eds. Perinatal Stem Cells. New York: Springer-Verlag; 2014:171–182.
8.
TitaATAndrewsWW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339–354.
9.
ZipurskyAPalkoJMilnerRAkenzuaI. The hematology of bacterial infections in premature infants. Pediatrics. 1976;57(6):839–853.
10.
NittalaSSubbaraoGCMaheshwariA. Evaluation of neutropenia and neutrophilia in preterm infants. J Matern Fetal Neonatal Med. 2012;25(suppl 5):100–103.
11.
BorzychowskiAMSargentILRedmanCW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11(5):309–316.
12.
ChaiworapongsaTChaemsaithongPYeoLRomeroR. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
13.
FraserSHTudehopeDI. Neonatal neutropenia and thrombocytopenia following maternal hypertension. J Paediatr Child Health. 1996;32(1):31–34.
14.
NeufeldMDFrigonCGrahamASMuellerBA. Maternal infection and risk of cerebral palsy in term and preterm infants. J Perinatol. 2005;25(2):108–113.
15.
ShevellAWintermarkPBeniniRShevellMOskouiM. Chorioamnionitis and cerebral palsy: lessons from a patient registry. Eur J Paediatr Neurol. 2014;18(3):301–307.
16.
KumarRYuYStoryRE. Prematurity, chorioamnionitis, and the development of recurrent wheezing: a prospective birth cohort study. J Allergy Clin Immunol. 2008;121(4):878–884. e876.
17.
BarkerDJ. The developmental origins of adult disease. Eur J Epidemiol. 2003;18(8):733–736.
18.
NorthTEde BruijnMStacyT. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity. 2002;16(5):661–672.
19.
UhlénmMFagerbergLHallströmBM. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.
20.
NorthTGuT-LStacyT. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 1999;126(11):2563–2575.
21.
ChenMJYokomizoTZeiglerBMDzierzakESpeckNA. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature. 2009;457(7231):887–891.
22.
ZapeJPZoveinAC. Hemogenic endothelium: origins, regulation, and implications for vascular biology. Semin Cell Dev Biol. 2011;22(9):1036–1047.
23.
BosFLHawkinsJSZoveinAC. Single-cell resolution of morphological changes in hemogenic endothelium. Development. 2015;142(15):2719–2724.
24.
ToberJYzaguirreADPiwarzykESpeckNA. Distinct temporal requirements for Runx1 in hematopoietic progenitors and stem cells. Development. 2013;140(18):3765–3776.
25.
OttersbachKDzierzakE. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell. 2005;8(3):377–387.
26.
HerronMAKatzMCreasyRK. Evaluation of a preterm birth prevention program: preliminary report. Obstetr Gynecol. 1982;59(4):452–456.
27.
ZhouYBiancoKHuangL. Comparative analysis of maternal-fetal interface in preeclampsia and preterm labor. Cell Tissue Res. 2007;329(3):559–569.
28.
RasbandWS. ImageJ. Bethesda, MD: US National Institutes of Health; 1997–2014.
29.
Roadmap Epigenomics Consortium. KundajeAMeulemanW. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–330.
30.
FaulFErdfelderELangA-GBuchnerA.G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191.
31.
McMasterMTLibrachCLZhouY. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol. 1995;154(8):3771–3778.
32.
CoradaMOrsenigoFMoriniMF. Sox17 is indispensable for acquisition and maintenance of arterial identity. Nat Commun. 2013;4:2609.
33.
Van HandelBPrashadSLHassanzadeh-KiabiN. The first trimester human placenta is a site for terminal maturation of primitive erythroid cells. Blood. 2010;116(17):3321–3330.
34.
SasakiTMizuochiCHorioYNakaoKAkashiKSugiyamaD. Regulation of hematopoietic cell clusters in the placental niche through SCF/Kit signaling in embryonic mouse. Development. 2010;137(23):3941–3952.
35.
de BruijnMFTRSpeckNAPeetersMCEDzierzakE. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J. 2000;19(11):2465–2474.
36.
Alvarez-SilvaMBelo-DiabangouayaPSalaunJDieterlen-LievreF. Mouse placenta is a major hematopoietic organ. Development. 2003;130(22):5437–5444.
37.
KatagiriTTakahashiN. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis. 2002;8(3):147–159.
38.
LiQItoKSakakuraC. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002;109(1):113–124.
39.
LevanonDBettounDHarris-CerrutiC. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 2002;21(13):3213–3567.
40.
Kalev-ZylinskaMLHorsfieldJAFloresMV. Runx3 is required for hematopoietic development in zebrafish. Dev Dyn. 2003;228(3):323–336.
41.
LevanonDBrennerONegreanuV. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mech Dev. 2001;109(2):413–417.
42.
Montero-RuizOAlcantara-OrtigozaMABetancourtMJuarez-VelazquezRGonzalez-MarquezHPerez-VeraP. Expression of RUNX1 isoforms and its target gene BLK in childhood acute lymphoblastic leukemia. Leuk Res. 2012;36(9):1105–1111.
43.
TessierDRYockell-LelievreJGruslinA. Uterine spiral artery remodeling: the role of uterine natural killer cells and extravillous trophoblasts in normal and high-risk human pregnancies. Am J Reprod Immunol. 2015;74(1):1–11.
44.
FisherSJ. Why is placentation abnormal in preeclampsia?Am J Obstet Gynecol. 2015;213(4 suppl):S115–S122.
45.
ZoveinACHofmannJJLynchM. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell. 2008;3(6):625–636.
46.
RichardCDrevonCCantoPY. Endothelio-mesenchymal interaction controls runx1 expression and modulates the notch pathway to initiate aortic hematopoiesis. Dev Cell. 2013;24(6):600–611.
47.
MedvinskyARybtsovSTaoudiS. Embryonic origin of the adult hematopoietic system: advances and questions. Development. 2011;138(6):1017–1031.
48.
BoissetJCvan CappellenWAndrieu-SolerCGaljartNDzierzakERobinC. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature. 2010;464(7285):116–120.
49.
TavianMCoulombelLLutonDClementeHSDieterlen-LievreFPeaultB. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood. 1996;87(1):67–72.
HeQZhangCWangL. Inflammatory signaling regulates hematopoietic stem and progenitor cell emergence in vertebrates. Blood. 2015;125(7):1098–1106.
56.
KotowskiMSafranowKKawaMP. Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns. BMC Pediatr. 2012;12:148–163.
57.
GekasCDieterlen-LievreFOrkinSHMikkolaHK. The placenta is a niche for hematopoietic stem cells. Dev Cell. 2005;8(3):365–375.
58.
WisgrillLSchullerSBammerM. Hematopoietic stem cells in neonates: any differences between very preterm and term neonates?PLoS One. 2014;9(9):e106717.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
